KLRS
Price
$7.10
Change
+$0.50 (+7.58%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
123.44M
23 days until earnings call
RNTX
Price
$1.46
Change
-$0.18 (-10.98%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
33.37M
Ad is loading...

KLRS vs RNTX

Header iconKLRS vs RNTX Comparison
Open Charts KLRS vs RNTXBanner chart's image
Kalaris Therapeutics
Price$7.10
Change+$0.50 (+7.58%)
Volume$100
Capitalization123.44M
Rein Therapeutics
Price$1.46
Change-$0.18 (-10.98%)
Volume$9.45K
Capitalization33.37M
KLRS vs RNTX Comparison Chart
Loading...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KLRS vs. RNTX commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLRS is a StrongBuy and RNTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (KLRS: $6.60 vs. RNTX: $1.64)
Brand notoriety: KLRS and RNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KLRS: 224% vs. RNTX: 118%
Market capitalization -- KLRS: $123.44M vs. RNTX: $33.37M
KLRS [@Biotechnology] is valued at $123.44M. RNTX’s [@Biotechnology] market capitalization is $33.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KLRS’s FA Score shows that 1 FA rating(s) are green whileRNTX’s FA Score has 1 green FA rating(s).

  • KLRS’s FA Score: 1 green, 4 red.
  • RNTX’s FA Score: 1 green, 4 red.
According to our system of comparison, KLRS is a better buy in the long-term than RNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLRS’s TA Score shows that 3 TA indicator(s) are bullish while RNTX’s TA Score has 3 bullish TA indicator(s).

  • KLRS’s TA Score: 3 bullish, 6 bearish.
  • RNTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RNTX is a better buy in the short-term than KLRS.

Price Growth

KLRS (@Biotechnology) experienced а -17.81% price change this week, while RNTX (@Biotechnology) price change was -7.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.88%. For the same industry, the average monthly price growth was -20.27%, and the average quarterly price growth was -19.68%.

Reported Earning Dates

KLRS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-9.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KLRS($123M) has a higher market cap than RNTX($33.4M). KLRS YTD gains are higher at: 1471.429 vs. RNTX (-28.696).
KLRSRNTXKLRS / RNTX
Capitalization123M33.4M368%
EBITDAN/AN/A-
Gain YTD1471.429-28.696-5,128%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
RNTX: Fundamental Ratings
RNTX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KLRSRNTX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMMEX14.20N/A
N/A
Northern Active M Emerging Market Equity
FSLEX32.87N/A
N/A
Fidelity Environment & Alternative Engy
BRGKX32.26N/A
N/A
iShares Russell 1000 Large-Cap Idx K
GMNAX9.79N/A
N/A
Gabelli Global Mini Mites A
NSBRX54.83-0.39
-0.71%
Nuveen Dividend Growth I

KLRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLRS has been loosely correlated with CHRO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if KLRS jumps, then CHRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLRS
1D Price
Change %
KLRS100%
-6.78%
CHRO - KLRS
41%
Loosely correlated
-3.94%
SPRO - KLRS
21%
Poorly correlated
+3.06%
ASBP - KLRS
3%
Poorly correlated
-11.07%
RNTX - KLRS
3%
Poorly correlated
-3.53%
OSRH - KLRS
2%
Poorly correlated
-21.54%
More

RNTX and

Correlation & Price change

A.I.dvisor tells us that RNTX and IKT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNTX and IKT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
-3.53%
IKT - RNTX
26%
Poorly correlated
-8.70%
ATOS - RNTX
25%
Poorly correlated
+7.75%
ERNA - RNTX
23%
Poorly correlated
-1.43%
CRGX - RNTX
23%
Poorly correlated
+0.25%
LENZ - RNTX
22%
Poorly correlated
-7.84%
More